SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Vascular Biogenics Ltd. (VBLT)

VBLT RSS Feed 		Add VBLT Price Alert      Hide Sticky   Hide Intro
Moderator: gr8db8
Search This Board: 
Last Post: 9/22/2017 6:30:52 PM - Followers: 34 - Board type: Free - Posts Today: 4

Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its clinical pipeline is based on two platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. As of June 6, 2014, it has developed two programs based on these platforms an oncology program and an anti-inflammatory program. Its lead product candidate from its oncology program, VB-111, is a gene-based biologic that is initially developing for recurrent glioblastoma (rGBM), an aggressive form of brain cancer. The Company has also received orphan drug designation in both the United States and Europe. The Company’s oncology program is based on its Vascular Targeting System (VTS), platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels. http://www.vblrx.com
SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
VBLT
Current Price
Volume:
Bid Ask Day's Range
VBLT Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VBLT News: Amended Statement of Beneficial Ownership (sc 13d/a) 09/18/2017 05:15:09 PM
VBLT News: Report of Foreign Issuer (6-k) 09/13/2017 04:32:33 PM
VBLT News: Securities Registration: Employee Benefit Plan (s-8) 08/14/2017 05:38:30 PM
VBLT News: Report of Foreign Issuer (6-k) 08/14/2017 07:02:00 AM
VBLT News: VBL Therapeutics Announces Second Quarter 2017 Financial Results 08/14/2017 07:00:00 AM
PostSubject
#1290   https://twitter.com/dslevine/status/908333520401031174 davidal66 09/22/17 06:30:52 PM
#1289   Correct mantoo123. This is what I wrote back gr8db8 09/22/17 04:51:14 PM
#1288   We know that the patients that enrolled in mantoo123 09/22/17 03:24:45 PM
#1287   Let us hope MM will keep it around staccani 09/22/17 12:22:03 PM
#1286   It is in the last conference here what Valueinvestor12 09/21/17 10:49:11 PM
#1285   Where did u see the cutoff date was Oren1976 09/21/17 10:27:30 PM
#1284   I believe vblt got the Positive 3rd DSMC Valueinvestor12 09/21/17 08:34:30 PM
#1283   VBLT manufactured VB111 and has a site where davidal66 09/21/17 08:26:09 PM
#1282   Agree davidal66. They may know those numbers in gr8db8 09/21/17 06:07:21 PM
#1281   The failure of VB-201 in psoriasis and ulcerative gr8db8 09/21/17 05:04:09 PM
#1280   And i also think that ph3 will provide staccani 09/21/17 01:00:02 PM
#1279   Agree wcopeland. Those are all good "signs" (including gr8db8 09/21/17 12:47:01 PM
#1278   Great post. I share your sentiments. mantoo123 09/21/17 09:45:06 AM
#1277   Agree, I am very confident that this will wcopeland 09/21/17 09:00:20 AM
#1276   Agree, with both, very unlikely they are not wcopeland 09/21/17 08:44:20 AM
#1275   They are blinded on trial by design and Jumpinjackas 09/21/17 06:43:52 AM
#1274   FDA agreed to not doing a futility/efficacy analysis staccani 09/21/17 02:21:04 AM
#1273   Gr8 is correct, the interim was cancelled in wcopeland 09/21/17 01:22:09 AM
#1272   The company is not really blinded IMHO. One davidal66 09/21/17 01:08:35 AM
#1271   I can't PM but to answer no but buckiii2 09/20/17 10:53:14 PM
#1270   They only have the final DSMC review before gr8db8 09/20/17 10:47:59 PM
#1269   They have not cancelled the interim and they staccani 09/20/17 08:43:17 PM
#1268   The quick enrollment has to say something. There Jumpinjackas 09/20/17 07:02:16 PM
#1267   Thanks for posting to the board mjw007 09/20/17 02:31:34 PM
#1266   End the week with $8+ Lucky40 09/20/17 02:13:27 PM
#1265   Thank you for the presentation link. mantoo123 09/20/17 12:54:25 PM
#1264   I also questioned the true reason for canceling gr8db8 09/20/17 11:45:30 AM
#1263   Re: insider's ownership. staccani 09/20/17 11:35:30 AM
#1262   September presentation out staccani 09/20/17 11:29:32 AM
#1261   Why no insider buying? Tootired001 09/20/17 11:12:25 AM
#1260   The company is formnally blinded to trial staccani 09/20/17 05:59:23 AM
#1259   I am using the same alias here as mantoo123 09/20/17 04:25:29 AM
#1258   August 14, 2017 company update from LifeSci Capital mantoo123 09/20/17 04:13:49 AM
#1257   Really great commentary lately! I've enjoyed reading these. wcopeland 09/20/17 01:06:19 AM
#1256   I believe the rise is not connected as Oren1976 09/20/17 01:00:07 AM
#1255   I will never forget CEO words in Hebrew Oren1976 09/20/17 12:58:52 AM
#1254   The median OS numbers for avastin and VB-111 gr8db8 09/20/17 12:42:50 AM
#1253   If you read my previous posts you will staccani 09/19/17 10:00:32 PM
#1252   On second thought, it could be they now davidal66 09/19/17 09:58:05 PM
#1251   Not sure what the catalyst is ..... but mjw007 09/19/17 09:44:50 PM
#1250   VBLT could run big here without news as davidal66 09/19/17 07:54:44 PM
#1249   Congrats to VBLT longs! I wonder if there davidal66 09/19/17 07:08:09 PM
#1248   $40 long term, short term maybe $11 Lucky40 09/19/17 05:39:28 PM
#1247   Looks like a good runner but how far? kpisme 09/19/17 04:14:06 PM
#1246   I don"t think that I would sell this Prov 09/19/17 03:20:55 PM
#1245   Doctors and patients are starting to learn that gr8db8 09/19/17 03:09:49 PM
#1244   After all I think VB111 could become Avastin staccani 09/19/17 02:58:58 PM
#1243   I won't be surprised if the soldiers of Oren1976 09/19/17 11:23:14 AM
#1242   How many "others" are self made billionaires? gr8db8 09/19/17 11:14:29 AM
#1241   There is a reason why you had to Jumpinjackas 09/19/17 10:32:46 AM
PostSubject
© 2017 InvestorsHub.Com, Inc.